Jefferies Financial Group Lowers Hikma Pharmaceuticals (HIK) Price Target to GBX 1,960

Share on StockTwits

Hikma Pharmaceuticals (LON:HIK) had its price objective reduced by Jefferies Financial Group from GBX 2,000 ($26.13) to GBX 1,960 ($25.61) in a research note issued to investors on Tuesday. Jefferies Financial Group currently has a buy rating on the stock.

HIK has been the topic of several other reports. JPMorgan Chase & Co. cut their target price on shares of Hikma Pharmaceuticals from GBX 1,800 ($23.52) to GBX 1,700 ($22.21) and set a neutral rating on the stock in a research report on Thursday, March 14th. HSBC lifted their target price on shares of Hikma Pharmaceuticals from GBX 1,225 ($16.01) to GBX 1,350 ($17.64) and gave the stock a reduce rating in a research report on Thursday, March 14th. Peel Hunt lowered their price target on shares of Hikma Pharmaceuticals from GBX 2,000 ($26.13) to GBX 1,870 ($24.43) and set a hold rating for the company in a report on Tuesday, March 12th. Numis Securities restated a hold rating and set a GBX 1,730 ($22.61) price target on shares of Hikma Pharmaceuticals in a report on Wednesday, March 13th. Finally, Barclays restated an equal weight rating on shares of Hikma Pharmaceuticals in a report on Wednesday, December 19th. One analyst has rated the stock with a sell rating, four have issued a hold rating and two have issued a buy rating to the company. The stock has an average rating of Hold and a consensus target price of GBX 1,808.57 ($23.63).

LON:HIK opened at GBX 1,752.50 ($22.90) on Tuesday. The company has a debt-to-equity ratio of 37.54, a quick ratio of 1.17 and a current ratio of 1.87. Hikma Pharmaceuticals has a one year low of GBX 1,078 ($14.09) and a one year high of GBX 2,089 ($27.30). The company has a market cap of $4.23 billion and a P/E ratio of 15.04.

The company also recently declared a dividend, which will be paid on Wednesday, May 22nd. Shareholders of record on Thursday, April 4th will be issued a dividend of $0.26 per share. This is a positive change from Hikma Pharmaceuticals’s previous dividend of $0.12. The ex-dividend date of this dividend is Thursday, April 4th. This represents a yield of 1.23%. Hikma Pharmaceuticals’s dividend payout ratio (DPR) is presently 0.34%.

In other news, insider Mary (Nina) Henderson purchased 2,000 shares of the stock in a transaction on Friday, March 15th. The stock was purchased at an average price of GBX 1,563 ($20.42) per share, for a total transaction of £31,260 ($40,846.73). Also, insider Mazen Darwazah acquired 20,000 shares of the stock in a transaction dated Wednesday, March 13th. The stock was bought at an average price of GBX 1,582 ($20.67) per share, with a total value of £316,400 ($413,432.64).

About Hikma Pharmaceuticals

Hikma Pharmaceuticals PLC develops, manufactures, and markets a range of generic, branded, and in-licensed pharmaceutical products in solid, semi-solid, liquid, and injectable final dosage forms. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment manufactures, markets, and sells generic injectable products for therapeutic categories, including anti-infective, anaesthetic, central nervous system (CNS), oncology, and pain management, as well as controlled substances and cardiovascular products.

Featured Story: What are Bollinger Bands?

Analyst Recommendations for Hikma Pharmaceuticals (LON:HIK)

Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Zacks: Brokerages Anticipate Newell Brands Inc  to Post $0.36 EPS
Zacks: Brokerages Anticipate Newell Brands Inc to Post $0.36 EPS
indaHash Price Hits $0.0054 on Top Exchanges
indaHash Price Hits $0.0054 on Top Exchanges
EP Wealth Advisors LLC Purchases 4,555 Shares of BlackRock, Inc.
EP Wealth Advisors LLC Purchases 4,555 Shares of BlackRock, Inc.
22,085 Shares in Alphabet Inc  Acquired by EP Wealth Advisors LLC
22,085 Shares in Alphabet Inc Acquired by EP Wealth Advisors LLC
OTA Financial Group L.P. Takes Position in DowDuPont Inc
OTA Financial Group L.P. Takes Position in DowDuPont Inc
McKesson Co.  Holdings Boosted by Holderness Investments Co.
McKesson Co. Holdings Boosted by Holderness Investments Co.


© 2006-2019 Ticker Report